1. Use anti-competitive vascular endocrine growth factor compounds selected from Ranbizumab or Aspergillus flavus, as well as remote monitoring and toolkits for the treatment of eye disorders, including remote devices, therapeutic agents and supply devices.

摘要

This invention is in the field of the treatment of eye disorders. In particular, it relates to the use of a remote monitoring system for determining patient response to therapeutic treatment, in particular with VEGF antagonists.